4.7 Article

OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death

Journal

EMBO MOLECULAR MEDICINE
Volume 11, Issue 3, Pages -

Publisher

WILEY
DOI: 10.15252/emmm.201809324

Keywords

cell death; deubiquitinases; inflammatory disease; TNF signalling; ubiquitin

Funding

  1. EU FP7 Infrastructure grant BIOSTRUCT-X [283570]
  2. Medical Research Council [U105192732]
  3. European Research Council [724804]
  4. Lister Institute for Preventive Medicine
  5. Marie-Sklodowska Curie Individual Fellowship from the European Commission [MC-IF-654019]
  6. Lundbeckfonden Postdoctoral Fellowship [R232-2016-1904/R265-2017-2998]
  7. Corpus Christi College Cambridge
  8. NIHR
  9. NIHR (Cambridge NIHR Biomedical Research Centre)
  10. NIHR Cambridge Biomedical Research Centre
  11. Deutsche Forschungsgemeinschaft (Discovery and Evaluation of new Combined Immunodeficiency Disease Entities) [DFG WA 1597/4-2]
  12. ERANET ERARE consortium (EURO-CID ERARE)
  13. MRC [MC_U105192732] Funding Source: UKRI

Ask authors/readers for more resources

The deubiquitinase OTULIN removes methionine-1 (M1)-linked polyubiquitin signals conjugated by the linear ubiquitin chain assembly complex (LUBAC) and is critical for preventing TNF-driven inflammation in OTULIN-related autoinflammatory syndrome (ORAS). Five ORAS patients have been reported, but how dysregulated M1-linked polyubiquitin signalling causes their symptoms is unclear. Here, we report a new case of ORAS in which an OTULIN-Gly281Arg mutation leads to reduced activity and stability in vitro and in cells. In contrast to OTULIN-deficient monocytes, in which TNF signalling and NF-kappa B activation are increased, loss of OTULIN in patient-derived fibroblasts leads to a reduction in LUBAC levels and an impaired response to TNF. Interestingly, both patient-derived fibroblasts and OTULIN-deficient monocytes are sensitised to certain types of TNF-induced death, and apoptotic cells are evident in ORAS patient skin lesions. Remarkably, haematopoietic stem cell transplantation leads to complete resolution of inflammatory symptoms, including fevers, panniculitis and diarrhoea. Therefore, haematopoietic cells are necessary for clinical manifestation of ORAS. Together, our data suggest that ORAS pathogenesis involves hyper-inflammatory immune cells and TNF-induced death of both leukocytes and non-haematopoietic cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available